Furthermore, the elevation of glucose level was recorded in CYP and/or R groups due to widespread β-cell destruction, as confirmed by [70, 71], who reported hyperglycemia following CYP and/or R therapy. The gene discussed is PPIG; the disease is Hyperglycemia.